Literature DB >> 15246695

Expression of alpha 5 GABAA receptor subunit in developing rat hippocampus.

Blanca Ramos1, Juan Felix Lopez-Tellez, Jose Vela, David Baglietto-Vargas, Juan Carlos del Rio, Diego Ruano, Antonia Gutierrez, Javier Vitorica.   

Abstract

The GABAergic system plays an important role in the hippocampal development. Here we have studied the developmental expression of the alpha 5 subunit of the GABA(A) receptor (from rat hippocampus) by RT-competitive PCR, immunoblot and immunocytochemistry. Our results demonstrated an early induction of the alpha 5 subunit expression (at mRNA and protein levels) during the first postnatal week, peaking at P5 and decreasing after this age. The peak of alpha 5 subunit expression precedes the peak of expression for the synaptophysin, GAD65 and GAD67. Thus, the increase in the alpha 5 GABA(A) receptor subunit expression may precede the GABAergic synaptogenesis. Importantly, between P0 and P7, the expression of the alpha 5 subunit was concentrated at the cell somata of the pyramidal and granular cells. After P10, its localization shifted from the cell bodies to the dendritic layers. This developmental pattern is similar to that reported for the Na(+)-K(+)-2Cl(-) system and it might be correlated with the transition from excitatory to inhibitory GABAergic activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246695     DOI: 10.1016/j.devbrainres.2004.04.003

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  18 in total

1.  Positive modulation of α5 GABAA receptors in preadolescence prevents reduced locomotor response to amphetamine in adult female but not male rats prenatally exposed to lipopolysaccharide.

Authors:  Bojan Batinić; Anja Santrač; Ivan Jančić; Guanguan Li; Aleksandra Vidojević; Bojan Marković; James M Cook; Miroslav M Savić
Journal:  Int J Dev Neurosci       Date:  2017-06-10       Impact factor: 2.457

Review 2.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

3.  A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.

Authors:  Kathryn M Gill; Daniel J Lodge; James M Cook; Shamim Aras; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

4.  Development of dendritic tonic GABAergic inhibition regulates excitability and plasticity in CA1 pyramidal neurons.

Authors:  Martine R Groen; Ole Paulsen; Enrique Pérez-Garci; Thomas Nevian; J Wortel; Marinus P Dekker; Huibert D Mansvelder; Arjen van Ooyen; Rhiannon M Meredith
Journal:  J Neurophysiol       Date:  2014-04-23       Impact factor: 2.714

Review 5.  Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia.

Authors:  Anthony A Grace
Journal:  Neuropharmacology       Date:  2011-05-23       Impact factor: 5.250

6.  Gene expression analysis of the embryonic subplate.

Authors:  Franziska M Oeschger; Wei-Zhi Wang; Sheena Lee; Fernando García-Moreno; André M Goffinet; Maria L Arbonés; Sonja Rakic; Zoltán Molnár
Journal:  Cereb Cortex       Date:  2011-08-22       Impact factor: 5.357

7.  Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Authors:  Kathryn M Gill; James M Cook; Michael M Poe; Anthony A Grace
Journal:  Schizophr Bull       Date:  2014-01-24       Impact factor: 9.306

8.  Development of gamma-aminobutyric acidergic synapses in cultured hippocampal neurons.

Authors:  Catherine Croft Swanwick; Namita R Murthy; Zakaria Mtchedlishvili; Werner Sieghart; Jaideep Kapur
Journal:  J Comp Neurol       Date:  2006-04-10       Impact factor: 3.215

9.  Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro.

Authors:  S K Towers; T Gloveli; R D Traub; J E Driver; D Engel; R Fradley; T W Rosahl; K Maubach; E H Buhl; M A Whittington
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

10.  Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.

Authors:  Jessica L Nuwer; Megan L Brady; Nadya V Povysheva; Amanda Coyne; Tija C Jacob
Journal:  Neuropharmacology       Date:  2021-07-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.